1.QualityMetric Incorporated,Lincoln,USA;2.Sanofi-Aventis recherche et développement,Paris,France;3.Pfizer Clinical Development and Medical Affairs,New London,USA;4.Queen Elizabeth II Health Sciences Centre,Halifax,Canada
Abstract:
Purpose
The Fatigue Impact Scale (FIS) has been used extensively to assess the impact of fatigue on health-related quality of life (HRQOL) in multiple sclerosis (MS). The objective of this study was to estimate the minimally important difference (MID) of the FIS to facilitate the interpretation of the scale in patients with MS.